Akèy › Fèbli Kognitif Lejè
Etid klinik pou Fèbli Kognitif Lejè ap rekrite nan Etazini
233 etid pou Fèbli Kognitif Lejè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY23 etid
- Boston, MA21 etid
- Chicago, IL17 etid
- Baltimore, MD16 etid
- Los Angeles, CA12 etid
- Miami, FL11 etid
- Philadelphia, PA11 etid
- Birmingham, AL11 etid
- Atlanta, GA10 etid
- San Francisco, CA10 etid
- Houston, TX10 etid
- St. Louis, MO9 etid
- Washington, DC9 etid
- Durham, NC9 etid
- Gainesville, FL8 etid
- Indianapolis, IN8 etid
- Phoenix, AZ8 etid
- Portland, OR8 etid
- Tampa, FL8 etid
- Columbus, OH7 etid
- Dallas, TX7 etid
- Charleston, SC6 etid
- Irvine, CA6 etid
- San Antonio, TX6 etid
- Providence, RI6 etid
- Hollywood, FL6 etid
- San Diego, CA6 etid
- Farmington Hills, MI6 etid
- Winston-Salem, NC5 etid
- Austin, TX5 etid
- Boulder, CO5 etid
- Seattle, WA5 etid
- New Haven, CT5 etid
- West Palm Beach, FL5 etid
- Pittsburgh, PA5 etid
- Jacksonville, FL5 etid
- The Bronx, NY5 etid
- Ann Arbor, MI5 etid
- Mountain View, CA5 etid
- Orlando, FL5 etid
Pa eta
- Alabama11 etid
- Arizona13 etid
- Arkansas3 etid
- Colorado13 etid
- Connecticut9 etid
- Distrik Columbia5 etid
- Florid27 etid
- Georgia12 etid
- Illinois21 etid
- Indiana11 etid
- Iowa3 etid
- Kalifòni41 etid
- Maryland23 etid
- Massachusetts27 etid
- Michigan11 etid
- Minnesota6 etid
- Mississippi3 etid
- Missouri11 etid
- New Hampshire3 etid
- New Jersey9 etid
- New York31 etid
- North Carolina16 etid
- Ohio11 etid
- Oregon10 etid
- Pennsylvania13 etid
- Rhode Island6 etid
- South Carolina8 etid
- Tennessee9 etid
- Texas24 etid
- Utah4 etid
- Virginia5 etid
- Washington6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Digital STEADI Efficacy
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07852650NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
Ap rekrite
Laj 55 a 90 · Tout sèks · Mizajou Oct 1, 2026 · NCT07667478PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
Ap rekriteFaz 1Volontè an sante akeyi
Laj 50 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT07169630Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
Ap rekriteVolontè an sante akeyi
Laj 56 a 85 · Tout sèks · Mizajou Sep 28, 2026 · NCT03954899Older Breast Cancer Patients: Risk for Cognitive Decline
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 a 105 · Fanm · Mizajou Sep 28, 2026 · NCT03451383A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470Benefits of Nicotinamide Riboside Upon Cognition and Sleep
Ap rekriteVolontè an sante akeyi
Laj 65 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT05500170A Study of LY3439539 in Participants With Alzheimer's Disease
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370taVNS + CCT for Neurocognitive Rehab
Ap rekrite
Laj 45 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07517237Combating Alzheimer's Through Sleep and Exercise
Ap rekriteVolontè an sante akeyi
Laj 55 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT04855630Predicting Pre-dementia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07516119A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07661355Music for Pain and Dementia
Ap rekrite
Laj 50 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07602283Microbiome in Aging of Gut and Brain
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07799402Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT04396873A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203Percepta for Cognitive Optimization
Ap rekrite
Laj 40 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT07612449Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
Ap rekriteEtid obsèvasyon
Laj 2 a 40 · Gason · Mizajou Sep 16, 2026 · NCT05600946Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04916210Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Ap rekriteEtid obsèvasyon
Laj 70 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06052397Study to Understand Novel Biomarkers in Researching Dementia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06547099Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment
Ap rekriteVolontè an sante akeyi
Laj 65 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07225400Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Ap rekriteFaz 1
Laj 8 a 17 · Tout sèks · Mizajou Sep 9, 2026 · NCT07226219Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.